Evrysdi for Infants Under 2 Months Old Given FDA Priority Review & Adapting to a New Wheelchair

SMA News Today’s multimedia associate, Price Wooldridge, discusses how the FDA is reviewing a request that the use of Evrysdi, an oral and at-home SMA treatment, be extended to pre-symptomatic babies.Also, although exciting, getting a new wheelchair isn’t always easy. DeAnn can relate to columnist Brianna Albers recent article, “A Year Later, I’m Still Wearing Old Shoes.” She goes into detail about the process and what she continues to struggle with. Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/